Bath & Body Works Reports 2025 First Quarter Results and Maintains Fiscal Year 2025 Guidance

Goldman Sachs Reiterates Buy Rating on Bath & Body Works Inc. (BBWI)

Goldman Sachs analyst Kate McShane reiterated a Buy rating and $43.00 price target on Bath & Body Works Inc. (NYSE: BBWI).

The analyst comments "BBWI is currently down 7.0% (vs. the S&P +0.2%) following its 1Q results, which were in line with the company's preannouncement on... More

Bath & Body Works Inc. (BBWI) PT Lowered to $41 at Morgan Stanley

Morgan Stanley analyst Alex Straton lowered the price target on Bath & Body Works Inc. (NYSE: BBWI) to $41.00 (from $43.00) while maintaining a Overweight rating.

The analyst comments "1Q result in-line w/ pre-announcement, albeit w/ negative surprises: 1) degree of 1Q sales upside, 2) 2Q guide miss, 3) noisy... More

Bath & Body Works Inc. (BBWI) PT Lowered to $37 at Piper Sandler

Piper Sandler analyst Korinne Wolfmeyer lowered the price target on Bath & Body Works Inc. (NYSE: BBWI) to $37.00 (from $39.00) while maintaining a Overweight rating.

The analyst comments "We continue to rate BBWI Overweight following strong FQ1 results and reiterated FY guidance, as management's... More

BMO Capital Reiterates Outperform Rating on Bath & Body Works Inc. (BBWI)

BMO Capital analyst Simeon Siegel reiterated an Outperform rating and $50.00 price target on Bath & Body Works Inc. (NYSE: BBWI).

The analyst comments "BBWI reported 1Q results in line with its pre-announcement, with notably strong GM (+160bps). As usual, management introduced 2Q expectations below-Street... More

Bath & Body Works, Inc. (BBWI) Tops Q1 EPS by 7c, Misses on Revenue; Offers FY26 EPS Guidance

Bath & Body Works, Inc. (NYSE: BBWI) reported Q1 EPS of $0.49, $0.07 better than the analyst estimate of $0.42. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.42 billion.

GUIDANCE:

Bath & Body Works, Inc. sees FY2026 EPS of $3.25-$3.60,... More